Jack W. Callicutt - Chief Financial Officer at GALECTIN THERAPEUTICS INC

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
GALT on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Jack W. Callicutt in GALECTIN THERAPEUTICS INC

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-184,956
Avg price
$5.41
Total value
-$1,000,450

Net

Past year
Shares
-184,956
Share %
-100%
Total value
-$1,000,450

Reported holdings for Jack W. Callicutt in GALECTIN THERAPEUTICS INC

Form 4 holding Chief Financial Officer

GALECTIN THERAPEUTICS INC

Security class
Restricted Stock Unit
Shares / value
100,000
Estimated value
$69,600
Report date
16 Jan 2026
Price
$1.16
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

GALECTIN THERAPEUTICS INC

Security class
Commno stock
Shares / value
7,614
Estimated value
$45,760
Report date
03 Nov 2025
Price
$6.01
Ownership
Direct
Form 4 holding Chief Financial Officer

GALECTIN THERAPEUTICS INC

Security class
Stock option (right to buy)
Shares / value
65,000
Estimated value
$0
Report date
16 Jan 2026
Price
$1.37
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Jack W. Callicutt in GALECTIN THERAPEUTICS INC

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .